Cargando…
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with...
Autores principales: | Agirre-Lizaso, Aloña, Huici-Izagirre, Maider, Urretabizkaia-Garmendia, Josu, Rodrigues, Pedro M., Banales, Jesus M., Perugorria, Maria J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605535/ https://www.ncbi.nlm.nih.gov/pubmed/37894344 http://dx.doi.org/10.3390/cancers15204977 |
Ejemplares similares
-
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
por: Esparza-Baquer, Aitor, et al.
Publicado: (2021) -
Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)
por: Riaño, Ioana, et al.
Publicado: (2020) -
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
por: Caballero-Camino, Francisco J., et al.
Publicado: (2023) -
Characterizing the Heterogeneity of Liver Cell Populations Under a NASH-Related Hepatotoxicant Using Single-Nuclei RNA Sequencing
por: Rodrigues, Pedro M., et al.
Publicado: (2020) -
Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)